Titan Pharmaceuticals (de) Accounts Payable

Titan Pharmaceuticals (de) (TTNP) currently reports a accounts payable of $77K as of December 2025. That compares with $200K in the prior-year period — down 61.9% year over year. Use the charts on this page to explore Titan Pharmaceuticals (de)'s accounts payable history and peer comparisons.

Titan Pharmaceuticals (de)'s accounts payable decreased from $200K to $77K — a 61.9% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Titan Pharmaceuticals (de) reported $77K in accounts payable as of December 2025. That compares with $200K in the prior-year period — down 61.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $77K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Titan Pharmaceuticals (de), and consider following TTNP for alerts when major investors trade the stock.

Titan Pharmaceuticals (de) is classified in the Healthcare sector. On accounts payable, it currently shows $77K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TTNP with unrelated industries.